G'day Winshift,While I agree that there may still be value in...

G'day Winshift,

While I agree that there may still be value in the company, the broking community will not (in all probability) back DR for a "new adventure". They have heard it all before. I think that the Board and DR need to face reality. They bet the farm and lost. A new leadership is required and like many others before, this company will basically need to go back to the start. I am thinking Factor Therapeutics (formerly Tissue Therapies) or perhaps Acrux, or Immutep. If the money is going to be raised by and for the current CEO to continue, then the issue price will be low and the dilution will be high. Rightly or wrongly, there will be a disconnect between the value and the share price as they cannot go on just drawing down on borrowed money. Unless they can moetise the oncology assets fro a better than expected valuation and get rid of the debt, they are in trouble. I still think that the dream is dead - sorry - I was a true believer too for way too long.

Cheers,

DDD